Back to top
more

Tempus AI, Inc. (TEM)

(Delayed Data from NSDQ)

$72.69 USD

72.69
15,928,284

+6.04 (9.06%)

Updated Aug 21, 2026 04:00 PM ET

After-Market: $71.94 -0.75 (-1.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 31% (77 out of 247)

Industry: Medical Info Systems

Zacks News

Andrew Rocco headshot

Beyond LLMs: How Propense.ai & Tempus AI are Shaking up Legacy Industries

While large language models have been the primary focus of Wall Street, the real asymmetric returns for savvy growth investors will likely come from lesser-known AI segments disrupting legacy industries. Firms like Propense.ai, with its AI-powered B2B cross-selling platform, are gaining traction.

Urmimala Biswas headshot

Tempus AI vs. Butterfly: Which AI Health Tech Stock is the Better Buy?

BFLY outpaces TEM with stronger upside, leaner valuation, and expanding global reach in AI-powered diagnostics.

Zacks Equity Research

Zacks Investment Ideas feature highlights: Palantir, Tempus AI and Comfort Systems USA

Palantir, Tempus AI and Comfort Systems USA are part of the Zacks Investment Ideas article.

Derek Lewis headshot

These 3 AI-Related Stocks Crushed Earnings

We continue to wade through the 2025 Q1 cycle, which has been notably positive for these three companies with AI exposure. How long will the theme persist?

Urmimala Biswas headshot

After 92% YTD Surge, Is Tempus AI a Buy on Trump's Executive Order?

President Donald Trump's new executive order aiming to cut U.S. drug prices could benefit Tempus AI.

Derek Lewis headshot

These AI Stocks Posted Robust Results: Time to Buy?

Several AI-related stocks have posted robust results throughout the Q1 earnings cycle, a list that includes Palantir and Tempus AI. Given their results, it's impossible to deny the staying power of AI, which is still likely in its early innings.

Urmimala Biswas headshot

Tempus AI Stock Surges 43% in Q1: Buy Now or Wait for Earnings?

TEM's Genomics unit is expected to report strong growth for the first quarter, banking on continued unit growth pick-up.

Zacks Equity Research

The Zacks Analyst Blog Highlights Tempus AI, AstraZeneca, iRhythm Technologies and SOPHiA GENETICS

Tempus AI, AstraZeneca, iRhythm Technologies and SOPHiA GENETICS are included in this Analyst Blog.

Urmimala Biswas headshot

Tempus AI Stock Sees 21% Gain in 3 Days: Is it a Buy After AZN Deal?

TEM stock rises for three successive days. Should you expect more upside ahead, or is it time to dump Tempus AI?

Urmimala Biswas headshot

Tempus AI vs. Doximity: Which AI in Healthcare Stock is a Better Buy?

Both TEM and DOCS are technology-intensive healthcare companies leveraging artificial intelligence to enhance their platforms. Which one is a better investment? Let's see.